Fingerprint
Dive into the research topics of 'Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: Analyses from the 7-year PRECiSE 3 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically